Psoriasis associated with ulcerative colitis and Crohn's disease

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 5, 2009, Pages 561-565

  Cohen, A D ^a,b   Dreiher, J ^a   Birkenfeld, S ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

Author keywords

Crohn's disease; Inflammatory bowel disease; Psoriasis; Ulcerative colitis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; ULCERATIVE COLITIS;

ADULT; AGED; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSORIASIS;

EID: 63849147057     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03031.x     Document Type: Article

References (39)

1. Torres MI, Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008 14 : 1972 1980.
2. Canbay A, Runzi M, Gieseler R et al. Generalized pustulous psoriasis: a novel extraintestinal manifestation of Crohn's disease?] Z Gastroenterol 2001 39 : 801 805 (in German).
3. Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn's disease. Gut 1968 9 : 17 21.
4. Hoffmann R, Schieferstein G, Schunter F, Jenss H. Re: Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1991 86 : 787 788.
5. Hughes S, Williams SE, Turnberg LA. Crohn's disease and psoriasis. N Engl J Med 1983 308 : 101.
6. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990 85 : 962 963.
7. Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003 48 : 805 821.
8. Rudikoff D, Baral J, Lebwohl M. Psoriasis and Crohn's disease. Mt Sinai J Med 1999 66 : 206.
9. Umeno J, Matsumoto T, Jo Y, Ichikawa M, Urabe K, Iida M. Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease. Inflamm Bowel Dis 2007 13 : 1188 1189.
10. Angelucci E, Cocco A, Viscido A, Vernia P, Caprilli R. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. Inflamm Bowel Dis 2007 13 : 1059 1061.
11. Peramiquel L, Puig L, Dalmau J, Ricart E, Roe E, Alomar A. Onset of flexural psoriasis during infliximab treatment for Crohn's disease. Clin Exp Dermatol 2005 30 : 713 714.
12. Aslandis S, Pyrpasopoulou A, Douma S, Triantafyllou A. Tumor necrosis factor-α antagonist-induced psoriasis: yet another paradox in medicine. Clin Rheumatol 2008 27 : 377 380.
13. Angelucci E, Cocco A, Viscido A, Vernia P, Caprilli R. Amother paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-α antagonist. Inflamm Bowel Dis 2007 13 : 1059 1061.
14. Severs GA, Lowlor TH, Purcell SM, Adler DJ, Thompson R. Cutaneous adverse reaction to inflicimab: report of psoriasis developing in 3 patients. Cutis 2007 80 : 231 237.
15. Wollina U, Hansel G, Koch A, Schonlebe J, Kostler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008 9 : 1 14.
16. Wolf N, Quaranta M, Prescott NJ et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 2008 45 : 114 116.
17. Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroentrol 2006 12 : 3628 3635.
18. Capon F, Di Meglio P, Szaub J et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007 122 : 201 206.
19. Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL 12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Human Genet 2007 80 : 273 290.
20. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008 8 : 458 466.
21. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 : 1461 1463.
22. Nuñez C, Dema B, Cenit MC et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis. Genes Immun 2008 9 : 289 293.
23. Nair RP, Ruether A, Stuart PE et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008 128 : 1653 1661.
24. Sanchez FO, Reddy MVPL, Sakuraba K, Stahle M, Alarcon-Riquelme ME. IFN-Regulatory Factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population. J Invest Dermatol 2008 128 : 1704 1709.
25. Dideberg V, Kristjansdottir G, Milani L et al. An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol General 2007 16 : 3008 3016.
26. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982 106 : 323 330.
27. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet 1974 1 : 956 958.
28. Gaspar L. [Simultaneous occurrence of oral lichen, psoriasis and ulcerative colitis]. Fogorv Sz 1982 75 : 152 154 (in Hungarian).
29. McEwen C, DiTata D, Lingg C, Porini A, Good A, Rankin T. Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. A comparative study. Arthritis Rheum 1971 14 : 291 318.
30. Verbov JL. The skin in patients with Crohn's disease and ulcerative colitis. Trans St Johns Hosp Dermatol Soc 1973 59 : 30 36.
31. Hidvegi E, Arato A, Szonyi L. [Simultaneous occurrence of ulcerative colitis and psoriasis in childhood]. Orv Hetil 1995 136 : 1257 1259 (in Hungarian).
32. Yamamoto T, Yokoyama A. Coexistence of psoriasis vulgaris, ulcerative colitis, and thyroid adenoma. J Dermatol 1997 24 : 275 276.
33. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008 216 : 152 155.
34. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001 3 : 404 408.
35. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immun Rev 2008 223 : 87 113.
36. Asarch A, Barak O, Loo DS, Gottlieb AB. Th17 cells: a new therapeutic target in inflammatory dermatoses. J Dermatolog Treat 2008 19 : 318 326.
37. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. New Engl J Med 2007 356 : 580 592.
38. Mannon PJ, Fuss IJ, Mayer L et al. Anti-interleukin-12 antibody for active Crohn's diseases. N Engl J Med 2004 351 : 2069 2079.
39. Aenerli D, Seitz M, Juni P, Villiger PM. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-α inhibitors. Rheumatology 2005 44 : 172 175.